Visikol
BICO’s 3rd Exit Under CEO Maria Forss: MatTek and Visikol to be Sold for $80M
BICO (STO: BICO) is selling two of its companies—MatTek and Visikol—to Sartorius (ETR: SRT3) for $80 million. The decision is part of BICO’s plan to focus on what it sees…
3D Printing News Briefs, October 9, 2021: Automation, Bioprinting, & More
We’re starting with new materials in today’s 3D Printing News Briefs, then moving on to automation, bioprinting, and business. B9Creations introduced new resins for 3D printed molds and production parts,…
Cellink-Organovo Lawsuit Over Bioprinting Patents is Far From Over
In the highly competitive biotechnology and pharmaceutical industries, hardware manufacturers are under a lot of pressure to provide the best, most efficient, and fastest platforms for researchers. Bioprinting, in particular,…
Cellink Acquires Two Startups for $50M, Grows Bioconvergence Offerings
Set in revolutionizing the bioconvergence healthcare segment, Swedish-American company Cellink (CLNK-B.ST) has acquired two new startups to expand its technology offerings: Germany-based Nanoscribe and U.S.-based Visikol. The company said the…
